Today's health news spans gender disparities in heart failure care, leprosy treatment advances, emerging biomarker technologies, outbreak response updates, regulatory enforcement actions, and cancer drug developments.

Women account for only 1 in 3 advanced heart failure referrals in the UK and Ireland despite carrying similar disease burden, highlighting a significant gender disparity in access to specialized cardiac care.

A monthly triple-drug combination of rifampin, moxifloxacin, and minocycline reduces the risk of type 1 reactions in Hansen disease (leprosy) patients, offering a more effective treatment regimen for managing immune complications.

Saliva and urine are emerging as promising alternative biomarker sources for rheumatology conditions including Sjögren syndrome, rheumatoid arthritis, and lupus nephritis, potentially improving non-invasive diagnostic capabilities.

The WHO reports that global response efforts are catching up with the Ebola outbreak in the Democratic Republic of Congo, where confirmed cases have reached 344 as containment measures intensify.

Medical device manufacturer Medline received a second FDA warning letter in two months for manufacturing quality standard violations, signaling persistent compliance issues in device production and safety protocols.

Oscar-winning actress Laura Dern shares her caregiver experience with idiopathic pulmonary fibrosis (IPF), advocating for improved physician empathy and patient resources in managing the serious lung disease.

GLP-1 medications used during pregnancy are associated with adverse obstetric outcomes, though evidence suggests underlying maternal diabetes and medication discontinuation rebound effects rather than the drugs themselves are primary drivers.

Chiauranib, an investigational drug, demonstrated efficacy in slowing progression of platinum-resistant or platinum-refractory ovarian cancer in a phase 3 trial, extending progression-free survival in these difficult-to-treat cases.